摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R,4S,5'S,6R,6'S,8R,10E,12S,13S,14E,16E,20R,24S)-6'-cyclohexyl-24-hydroxy-12-[(4S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one

中文名称
——
中文别名
——
英文名称
(1R,4S,5'S,6R,6'S,8R,10E,12S,13S,14E,16E,20R,24S)-6'-cyclohexyl-24-hydroxy-12-[(4S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one
英文别名
——
(1R,4S,5'S,6R,6'S,8R,10E,12S,13S,14E,16E,20R,24S)-6'-cyclohexyl-24-hydroxy-12-[(4S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one化学式
CAS
——
化学式
C43H64O10
mdl
——
分子量
741.0
InChiKey
LNASWLBIATYITH-ZEYMBTCOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    53
  • 可旋转键数:
    4
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.79
  • 拓扑面积:
    122
  • 氢给体数:
    2
  • 氢受体数:
    10

文献信息

  • Method for enhancing folding and transport of misfolded glucocerebrosidase
    申请人:The Hospital for Sick Children
    公开号:US10028922B2
    公开(公告)日:2018-07-24
    Therapeutic compositions and methods for treatment of late-onset Gaucher disease are described herein. The compositions comprise compounds having activity as pharmacological chaperones for mutant forms of the beta-glucocerebrosidase. Methods of treatment involve providing therapeutically effective amounts of such compositions to subjects in need thereof.
    本文描述了治疗晚发型戈谢病的治疗组合物和方法。这些组合物包括对突变形式的β-葡糖脑苷脂具有药理伴侣活性的化合物。治疗方法包括向有需要的受试者提供治疗有效量的此类组合物。
  • Method of treating gaucher disease
    申请人:Mahuran Don J.
    公开号:US20090075960A1
    公开(公告)日:2009-03-19
    Therapeutic compositions and methods for treatment of late-onset Gaucher disease are described herein. The compositions comprise compounds having activity as pharmacological chaperones for mutant forms of the beta-glucocerebrosidase. Methods of treatment involve providing therapeutically effective amounts of such compositions to subjects in need thereof.
  • METHOD OF TREATING GAUCHER DISEASE
    申请人:The Hospital For Sick Children
    公开号:US20130090388A1
    公开(公告)日:2013-04-11
    Therapeutic compositions and methods for treatment of late-onset Gaucher disease are described herein. The compositions comprise compounds having activity as pharmacological chaperones for mutant forms of the beta-glucocerebrosidase. Methods of treatment involve providing therapeutically effective amounts of such compositions to subjects in need thereof.
  • METHOD FOR ENHANCING FOLDING AND TRANSPORT OF MISFOLDED GLUCOCEREBROSIDASE
    申请人:The Hospital for Sick Children
    公开号:US20140249233A1
    公开(公告)日:2014-09-04
    Therapeutic compositions and methods for treatment of late-onset Gaucher disease are described herein. The compositions comprise compounds having activity as pharmacological chaperones for mutant forms of the beta-glucocerebrosidase. Methods of treatment involve providing therapeutically effective amounts of such compositions to subjects in need thereof.
  • Method For Enhancing Folding and Transport of Misfolded Glucocerebrosidase
    申请人:The Hospital for Sick Children
    公开号:US20160113892A1
    公开(公告)日:2016-04-28
    Therapeutic compositions and methods for treatment of late-onset Gaucher disease are described herein. The compositions comprise compounds having activity as pharmacological chaperones for mutant forms of the beta-glucocerebrosidase. Methods of treatment involve providing therapeutically effective amounts of such compositions to subjects in need thereof.
查看更多